DOI 10.1016/j.ejmech.2026.118997
From fragments to drugs: How AI and in silico methods accelerate fragment-to-lead optimization.
Аннотация
Fragment-based drug design (FBDD) has become a key approach for mapping chemical space by starting with small, low-affinity fragments and building them into potent leads. Although these fragments bind weakly, strategies like fragment merging and linking can convert them into high-affinity molecules. More recently, Artificial Intelligence (AI) and Machine Learning (ML) have sped up this workflow by powering structure-guided optimization and generative design of new compounds. This review presents the state of FBDD: from biophysical screening and rapid structure elucidation to fragment growing, merging, and linking that elevate affinity while preserving ligand efficiency and drug-like properties. In particular, this review focuses on the integration of AI/ML approaches within these workflows. We compare experimental and computational strategies, summarize representative case studies, and assess how AI/ML now supports hit triage, compound priorization, and efficient exploration of chemical space. By emphasizing the role of AI-driven methods within established FBDD pipelines, we aim to provide a perspective on how these approaches complement traditional strategies. Limitations, common artifacts, and validation practices are discussed to clarify what reliably works and where open challenges remain in FBDD.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.